E2F2 and breast carcinoma: Lin et al. [44] confirmed that miRNA‐638 inhibited the biological behavior of breast cancer stem cells by interacting with E2F2. Moreover, it is well documented that E2F2 can serve as an attractive therapeutic target and biomarker for ovarian cancer [42].